UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051803
Receipt number R000059118
Scientific Title A study to evaluate the effect after using baby diaper,XIII
Date of disclosure of the study information 2023/08/02
Last modified on 2023/08/02 21:27:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to evaluate the effect after using baby diaper

Acronym

A study to evaluate the effect after using baby diaper

Scientific Title

A study to evaluate the effect after using baby diaper,XIII

Scientific Title:Acronym

A study to evaluate the effect after using baby diaper

Region

Japan


Condition

Condition

Healthy baby

Classification by specialty

Dermatology Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the dermatological effect after using baby diaper

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Skin condition before the use of test diaper, after 2 weeks.

Key secondary outcomes

- inflammatory cytokine


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Use the test diaper for 14 days.

Interventions/Control_2

Use the control diaper for 14 days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

3 months-old <=

Age-upper limit

10 months-old >=

Gender

Male and Female

Key inclusion criteria

1. 3 to 10 months living in Japan (Honshu) (4-9kg) Japanese infant
2. Infants who use tape-type S size diaper or M size diaper diaper all day.
3. Infants whose parents admit that they are worried about diaper dermatitis.

Key exclusion criteria

1. Infants who are under medical treatment or on medication for skin trouble.
2. Infants who were diagnosed with any disease among chronic disease and congenital disorder.
3. Infants who were affected with infectious disorder from one month before the start of the test to the start of the test.
4. Infants who used antibiotics, steroids, from one month before the start of the test to the start of the tes
5. Infants with skin disease on the diaper covering (up to moderate diaper dermatitis is not excluded).
6. Infants who had diarrhea from 1 week before the start of the study to the start of the study.
7. An infant whose head is not fully upright.
8. Infants judged by the researcher to be unsuitable for study participants.

Target sample size

77


Research contact person

Name of lead principal investigator

1st name Yuko
Middle name
Last name Fukuda

Organization

Kao Corporation

Division name

Sanitary Products Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7428

Email

fukuda.yuuko1@kao.com


Public contact

Name of contact person

1st name Sanae
Middle name
Last name Sagara

Organization

Kao Corporation

Division name

Sanitary Products Research

Zip code

321-3497

Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

+81-285-68-7428

Homepage URL


Email

sagara.sanae@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 07 Month 15 Day

Date of IRB

2023 Year 07 Month 19 Day

Anticipated trial start date

2023 Year 09 Month 03 Day

Last follow-up date

2023 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 02 Day

Last modified on

2023 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059118


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name